PBLA Chart
See on advanced chart >
About
Panbela Research, Inc. was originally incorporated in Delaware in September 2011. The company is a clinical-stage biopharmaceutical company focused on developing SBP-101, a proprietary small molecule polyamine metabolic inhibitor delivered subcutaneously for...
Read More
- HighlightA clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer
- ExchangeNASDAQ
- Listing Date08/28/2020
- Established DateInvalid Date
- Full-time Employees6
- Address712 Vista Blvd Suite 305 Waconia Minnesota 55387
- Tel1-952-4791196
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry